In an attempt to improve the quality assurance of treatment delivery In-Vivo Dosimetry was recommended by both Towards Safer Radiotherapy and the Chief Medical Officer in 2006. How to implement this effectively and efficiently still remains a challenge.
In-Vivo Dosimetry and Dose-Guided Radiotherapy
Dec 7th, 2011Dec 8th, 2011
London, --
GB
Latest in Home
Meet the Minnies 2025 semifinalist candidates
October 13, 2025
U.S. FDA may need to clarify SaMD validation standards
October 10, 2025
PSMA-PET/CT may replace NaF-PET/CT in advanced prostate cancer
October 10, 2025